Early identification of risk factors for sudden cardiac death

Nature Reviews Cardiology

Volumn 7, Issue 6, 2010, Pages 318-326

  Chugh, Sumeet S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GENE PRODUCT; PROTEIN CACNA1C; PROTEIN CACNB2; PROTEIN GPC4; PROTEIN GPC5; PROTEIN GPC6; PROTEIN GPD1L; PROTEIN LQTS; PROTEIN LQTS3; PROTEIN NOS1AP; PROTEIN SCN1B; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HUMAN; LONG QT SYNDROME; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH; SYMPTOMATOLOGY;

DEATH, SUDDEN, CARDIAC; GENETIC MARKERS; GENETIC VARIATION; HUMANS; PHENOTYPE; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; SYSTOLE; TIME FACTORS; UNITED STATES; VENTRICULAR FUNCTION, LEFT;

EID: 77953028869     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/nrcardio.2010.52     Document Type: Review

References (90)

1. Chugh, S. S. et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis. 51, 213-228 (2008).
2. Nichol, G. et al. Regional variation in out-of-hospital cardiac arrest incidence and outcome. JAMA 300, 1423-1431 (2008).
3. Chugh, S. S. et al. Current burden of sudden cardiac death: multiple source surveillance versus retrospective death certificate-based review in a large U.S. community. J. Am. Coll. Cardiol. 44, 1268-1275 (2004).
4. Zipes, D. P. & Wellens, H. J. Sudden cardiac death. Circulation 98, 2334-2351 (1998).
5. Huikuri, H.V., Castellanos, A. & Myerburg, R. J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. 345, 1473-1482 (2001).
6. Goldenberg, I., Zareba, W. & Moss, A. J. Long QT Syndrome. Curr. Probl. Cardiol. 33, 629-694 (2008).
7. Maron, B. J. Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation 121, 445-456 (2010).
8. Bardy, G. H. et al. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225-237 (2005).
9. Moss, A. J. et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877-883 (2002).
10. Myerburg, R. J., Mitrani, R., Interian, A., Jr & Castellanos, A. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation 97, 1514-1521 (1998).
11. de Vreede-Swagemakers, J. J. et al. Out-of-hospital cardiac arrest in the 1990s: a population-based study in the Maastricht area on incidence, characteristics and survival. J. Am. Coll. Cardiol. 30, 1500-1505 (1997).
12. Gorgels, A. P., Gijsbers, C., de Vreede- Swagemakers, J., Lousberg, A. & Wellens, H. J. Out-of-hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur. Heart J. 24, 1204-1209 (2003).
13. Stecker, E. C. et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. J. Am. Coll. Cardiol. 47, 1161-1166 (2006).
14. Goldberger, J. J. et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. Circulation 118, 1497-1518 (2008).
15. Camm, A. J. et al. Mortality in patients after a recent myocardial infarction: a randomized, placebo-controlled trial of azimilide using heart rate variability for risk stratification. Circulation 109, 990-996 (2004).
16. La Rovere, M. T. et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 103, 2072-2077 (2001).
17. Galinier, M. et al. Prognostic value of late potentials in patients with congestive heart failure. Eur. Heart J. 17, 264-271 (1996).
18. Silverman, M. E. et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am. J. Cardiol. 75, 460-464 (1995).
19. Costantini, O. et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J. Am. Coll. Cardiol. 53, 471-479 (2009).
20. Gold, M. R. et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118, 2022-2028 (2008).
21. Rosenbaum, D. S. et al. Electrical alternans and vulnerability to ventricular arrhythmias. N. Engl. J. Med. 330, 235-241 (1994).
22. Haider, A. W., Larson, M. G., Benjamin, E. J. & Levy, D. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J. Am. Coll. Cardiol. 32, 1454-1459 (1998).
23. Straus, S. M. et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J. Am. Coll. Cardiol. 47, 362-367 (2006).
24. Callans, D. J., Menz, V., Schwartzman, D., Gottlieb, C. D. & Marchlinski, F. E. Repetitive monomorphic tachycardia from the left ventricular outflow tract: electrocardiographic patterns consistent with a left ventricular site of origin. J. Am. Coll. Cardiol. 29, 1023-1027 (1997).
25. Chugh, S. S. et al. Population-based analysis of sudden death in children: The Oregon Sudden Unexpected Death Study. Heart Rhythm 6, 1618-1622 (2009).
26. Chugh, S. S. et al. Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study. Circulation 119, 663-670 (2009).
27. Chugh, S. S. et al. A community-based evaluation of sudden death associated with therapeutic levels of methadone. Am. J. Med. 121, 66-71 (2008).
28. Chugh, S. S. et al. Women have a lower prevalence of structural heart disease as a precursor to sudden cardiac arrest: The Ore- SUDS (Oregon Sudden Unexpected Death Study). J. Am. Coll. Cardiol. 54, 2006-2011 (2009).
29. Reddy, P. R. et al. Physical activity as a trigger of sudden cardiac arrest: the Oregon Sudden Unexpected Death Study. Int. J. Cardiol. 131, 345-349 (2009).
30. Reinier, K. et al. Incidence of sudden cardiac arrest is higher in areas of low socioeconomic status: a prospective two year study in a large United States community. Resuscitation 70, 186-192 (2006).
31. Stecker, E. C. et al. Allelic variants of SCN5A and risk of sudden cardiac arrest in patients with coronary artery disease. Heart Rhythm 3, 697-700 (2006).
32. Lemmert, M. E. et al. Electrocardiographic factors playing a role in ischemic ventricular fibrillation in ST elevation myocardial infarction are related to the culprit artery. Heart Rhythm 5, 71-78 (2008).
33. Das, M. K. & Zipes, D. P. Fragmented QRS: a predictor of mortality and sudden cardiac death. Heart Rhythm 6, S8-S14 (2009).
34. Dyer, A. R. et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am. J. Epidemiol. 112, 736-749 (1980).
35. Jouven, X., Zureik, M., Desnos, M., Guerot, C. & Ducimetiere, P. Resting heart rate as a predictive risk factor for sudden death in middleaged men. Cardiovasc. Res. 50, 373-378 (2001).
36. Kannel, W. B., Kannel, C., Paffenbarger, R. S., Jr & Cupples, L. A. Heart rate and cardiovascular mortality: the Framingham Study. Am. Heart J. 113, 1489-1494 (1987).
37. Shaper, A. G., Wannamethee, G., Macfarlane, P. W. & Walker, M. Heart rate, ischaemic heart disease, and sudden cardiac death in middle-aged British men. Br. Heart J. 70, 49-55 (1993).
38. Jouven, X. et al. Excessive heart rate increase during mild mental stress in preparation for exercise predicts sudden death in the general population. Eur. Heart J. 30, 1703-1710 (2009).
39. Albert, C. M. et al. Prospective study of sudden cardiac death among women in the United States. Circulation 107, 2096-2101 (2003).
40. Balkau, B., Jouven, X., Ducimetiere, P. & Eschwege, E. Diabetes as a risk factor for sudden death. Lancet 354, 1968-1969 (1999).
41. Jouven, X. et al. Diabetes, glucose level, and risk of sudden cardiac death. Eur. Heart J. 26, 2142-2147 (2005).
42. Friedlander, Y. et al. Sudden death and myocardial infarction in first degree relatives as predictors of primary cardiac arrest. Atherosclerosis 162, 211-216 (2002).
43. Friedlander, Y. et al. Family history as a risk factor for primary cardiac arrest. Circulation 97, 155-160 (1998).
44. Jouven, X., Desnos, M., Guerot, C. & Ducimetiere, P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 99, 1978-1983 (1999).
45. Dekker, L. R. et al. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Circulation 114, 1140-1145 (2006).
46. Kaikkonen, K. S., Kortelainen, M. L., Linna, E. & Huikuri, H. V. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Circulation 114, 1462-1467 (2006).
47. Arking, D. E., Chugh, S. S., Chakravarti, A. & Spooner, P. M. Genomics in sudden cardiac death. Circ. Res. 94, 712-723 (2004).
48. Prutkin, J. M. & Sotoodehnia, N. Genetics of sudden cardiac arrest. Prog. Cardiovasc. Dis. 50, 390-403 (2008).
49. Wellens, H. J., de Vreede, J. & Gorgels, A. P. Sudden cardiac death. How to reduce the number of victims? Eur. Heart J. 16 (Suppl. G), 7-9 (1995).
50. Moss, A. J. & Robinson, J. Clinical features of the idiopathic long QT syndrome. Circulation 85, I140-I144 (1992).
51. Schwartz, P. J. & Locati, E. The idiopathic long QT syndrome: pathogenetic mechanisms and therapy. Eur. Heart J. 6 (Suppl. D), 103-114 (1985).
52. Chiang, C. E. & Roden, D. M. The long QT syndromes: genetic basis and clinical implications. J. Am. Coll. Cardiol. 36, 1-12 (2000).
53. Keating, M. T. & Sanguinetti, M. C. Molecular genetic insights into cardiovascular disease. Science 272, 681-685 (1996).
54. Moss, A. J. et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 92, 2929-2934 (1995).
55. Schwartz, P. J. et al. Genotype-phenotype correlation in the long-QT syndrome: genespecific triggers for life-threatening arrhythmias. Circulation 103, 89-95 (2001).
56. Kaufman, E. S. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Heart Rhythm 6, S51-S55 (2009).
57. Antzelevitch, C. Brugada syndrome. Pacing Clin. Electrophysiol. 29, 1130-1159 (2006).
58. Brugada, P. & Brugada, J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J. Am. Coll. Cardiol. 20, 1391-1396 (1992).
59. Gussak, I., Antzelevitch, C., Bjerregaard, P., Towbin, J. A. & Chaitman, B. R. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J. Am. Coll. Cardiol. 33, 5-15 (1999).
60. Crotti, L. et al. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation 120, 1657-1663 (2009).
61. Eijgelsheim, M. et al. Genetic variation in NOS1AP is associated with sudden cardiac death: evidence from the Rotterdam Study. Hum. Mol. Genet. 18, 4213-4218 (2009).
62. Kao, W. H. et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white communitybased populations. Circulation 119, 940-951 (2009).
63. Arking, D. E. et al. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS ONE 5, e9879 (2010).
64. Esko, J. D. & Selleck, S. B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71, 435-471 (2002).
65. Rosenberg, R. D., Shworak, N. W., Liu, J., Schwartz, J. J. & Zhang, L. Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J. Clin. Invest. 100, S67-S75 (1997). (Pubitemid 28009550)
66. Pilia, G. et al. Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome. Nat. Genet. 12, 241-247 (1996).
67. Veugelers, M. et al. GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome. Genomics 53, 1-11 (1998).
68. Campos-Xavier, A. B. et al. Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia. Am. J. Hum. Genet. 84, 760-770 (2009).
69. Guttmacher, A. E., McGuire, A. L., Ponder, B. & Stefansson, K. Personalized genomic information: preparing for the future of genetic medicine. Nat. Rev. Genet. 11, 161-165 (2010).
70. Albert, C. M., Ma, J., Rifai, N., Stampfer, M. J. & Ridker, P. M. Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death. Circulation 105, 2595-2599 (2002).
71. Korngold, E. C. et al. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation 119, 2868-2876 (2009).
72. Chugh, S. S. & Reinier, K. Predicting sudden death in the general population: another step, N terminal B-type natriuretic factor levels. Circulation 119, 2863-2864 (2009).
73. Jouven, X., Charles, M. A., Desnos, M. & Ducimetiere, P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation 104, 756-761 (2001).
74. Lemaitre, R. N., King, I. B., Mozaffarian, D., Sotoodehnia, N. & Siscovick, D. S. Trans-fatty acids and sudden cardiac death. Atheroscler. Suppl. 7, 13-15 (2006).
75. Lemaitre, R. N. et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation 105, 697-701 (2002).
76. Empana, J. P. et al. Clinical depression and risk of out-of-hospital cardiac arrest. Arch. Intern. Med. 166, 195-200 (2006).
77. Katz, A. M. Trans-fatty acids and sudden cardiac death. Circulation 105, 669-671 (2002).
78. Marfella, R. et al. Elevated plasma fatty acid concentrations prolong cardiac repolarization in healthy subjects. Am. J. Clin. Nutr. 73, 27-30 (2001).
79. John, B. T. et al. Global remodeling of the ventricular interstitium in idiopathic myocardial fibrosis and sudden cardiac death. Heart Rhythm 1, 141-149 (2004).
80. Yan, A. T. et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 114, 32-39 (2006).
81. Wu, K. C. et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 51, 2414-2421 (2008).
82. Kehr, E., Sono, M., Chugh, S. S. & Jerosch-Herold, M. Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int. J. Cardiovasc. Imaging 24, 61-68 (2008).
83. Sosnovik, D. E. et al. Magnetic resonance imaging of cardiomyocyte apoptosis with a novel magneto-optical nanoparticle. Magn. Reson. Med. 54, 718-724 (2005).
84. Zipes, D. P. et al. Sudden cardiac death. Neural- cardiac interactions. Circulation 76, I202-I207 (1987).
85. Tamaki, S. et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. J. Am. Coll. Cardiol. 53, 426-435 (2009).
86. Mazzadi, A. N. et al. Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ. Cardiovasc. Imaging 2, 365-372 (2009).
87. Spooner, P. M. et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 103, 2361-2364 (2001).
88. Spooner, P. M. et al. Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part II. Circulation 103, 2447-2452 (2001).
89. Zipes, D. P. Sudden cardiac death. Future approaches. Circulation 85, I160-I166 (1992).
90. Myerburg, R. J. Scientific gaps in the prediction and prevention of sudden cardiac death. J. Cardiovasc. Electrophysiol. 13, 709-723 (2002).